Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,810 | 795 | 1,798 | 2,435 | 3,284 |
| TOTAL | $6,065 | $1,360 | $2,305 | $2,988 | $3,823 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 32 | 33 | 34 | 35 | 37 |
| TOTAL | $32 | $33 | $34 | $35 | $37 |
| Total Assets | $6,097 | $1,393 | $2,339 | $3,023 | $3,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,104 | 1,482 | 1,471 | 937 | 166 |
| Accrued Expenses | 745 | 741 | 695 | 352 | 440 |
| TOTAL | $1,849 | $2,223 | $2,278 | $1,511 | $935 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,849 | $2,223 | $2,278 | $1,511 | $935 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,862 | 510 | 142 | 116 | 96 |
| Retained earnings | -85,464 | -84,591 | -83,633 | -81,924 | -80,460 |
| TOTAL | $4,248 | $-830 | $62 | $1,512 | $2,925 |
| Total Liabilities And Equity | $6,097 | $1,393 | $2,339 | $3,023 | $3,859 |